Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Albany Molecular Res (AMRI)

Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Albany Molecular Res 26 CORPORATE CIRCLE ALBANY NY 12212 USA

www.amriglobal.com P: 518-512-2000

Description:

Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical development, analytical chemistry services and small-scale and pilot-plant manufacturing. Recently, they expanded their service offerings to include commercial manufacturing through their strategic relationship with and investment in Organichem Corporation.

Key Statistics

Overview:

Market Capitalization, $K 937,429
Shares Outstanding, K 43,120
Annual Sales, $ 570,450 K
Annual Net Income, $ -70,170 K
Last Quarter Sales, $ 172,930 K
Last Quarter Net Income, $ -10,250 K
60-Month Beta 1.17
% of Insider Shareholders 14.50%
% of Institutional Shareholders 72.10%

Growth:

1-Year Return 48.90%
3-Year Return 11.66%
5-Year Return 554.82%
5-Year Revenue Growth 174.72%
5-Year Earnings Growth -278.57%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.13 on 05/09/17
Next Earnings Date 09/07/17
Earnings Per Share ttm 0.57
EPS Growth vs. Prev Qtr -56.67%
EPS Growth vs. Prev Year 85.71%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 08/25/00

AMRI Ratios

Ratio
Price/Earnings ttm 24.43
Price/Earnings forward 23.89
Price/Earnings to Growth N/A
Return-on-Equity % 4.64%
Return-on-Assets % 1.19%
Profit Margin % -12.30%
Debt/Equity 2.02
Price/Sales 1.64
Price/Cash Flow 10.88
Price/Book 2.95
Book Value/Share 7.38
Interest Coverage 0.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar